Qure AI
Qure.ai, founded in 2016, leverages artificial intelligence to enhance healthcare accessibility and affordability, with its solutions deployed in over 2,600 sites across 90+ countries, impacting over 10 million lives.
History of Qure.ai
Qure.ai was founded in 2016 with the mission to use artificial intelligence to make healthcare more accessible and affordable. Since its inception, Qure.ai has expanded its AI solutions' reach to over 2,600 sites across more than 90 countries, impacting the lives of over 10 million people. The company has focused on developing advanced AI-powered tools that facilitate faster and more accurate medical diagnoses.
AI-Powered Healthcare Solutions by Qure.ai
Qure.ai offers a range of AI-powered healthcare solutions designed to improve the efficiency and accuracy of medical diagnoses. These solutions include chest X-ray reporting, TB care cascades, lung nodule management, stroke and TBI detection, MSK X-ray reporting, and heart failure diagnosis. Key products include qXR, qER, qMSK, and qTrack, each tailored to specific diagnostic needs. These tools have been designed to reduce turnaround times and improve the overall accuracy of medical reporting, significantly advancing healthcare accessibility.
Qure.ai's qXR Tool
The qXR tool by Qure.ai is a chest X-ray reporting solution that can process scans in less than 20 seconds. It boasts a high negative predictive value of 99% for segregating unremarkable chest X-rays and a 99.8% predictive value for lung nodules. This tool reduces the turnaround time for reporting by 40% and achieved a 91.5% AUC score for identifying lung nodules. The qXR-LN variant, approved by the US FDA 510(k), is specifically designed for identifying and marking regions related to suspected pulmonary nodules on chest X-rays.
Qure.ai's qER Tool
Qure.ai's qER tool is designed for rapid stroke and traumatic brain injury (TBI) diagnosis. It can reduce door-to-reporting time by 96% and alert stroke care teams within 5 minutes. The qER tool processes over 1 million scans annually. The qER (V2.0) tool, cleared by the US FDA 510(k), assists in workflow triage by flagging suspected positive findings in head CT images. Another variant, the qER-Quant, is FDA cleared for labeling, visualization, and quantification of brain structures from non-contrast head CT images.
Regulatory and Certification Credentials of Qure.ai
Qure.ai's AI solutions have received significant regulatory approvals and certifications. The company's products hold US FDA 510(k) clearances for various medical AI tools, including qXR-LN, qER (V2.0), qER-Quant, and other specialized diagnostic solutions. Qure.ai has also obtained Class IIa and IIb CE certifications under the European Union Medical Device Directive and Medical Device Regulation. The company's regulatory presence spans over 85 countries, including Canada, Brazil, Australia, and many ASEAN countries. Additionally, Qure.ai is ISO 13485:2016 MDSAP certified and ISO 27001 certified for information security.